Long-term effects of irbesartan on plasma aldosterone concentration and left atrial volume in hypertensive patients-Reference-Cited by-同舟云学术

Long-term effects of irbesartan on plasma aldosterone concentration and left atrial volume in hypertensive patients

Published:2014-03 Issue:3 Volume:63 Page:205-210
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Masaki Mitsuru,Komamura Kazuo,Goda Akiko,Hirotani Shinichi,Otsuka Misato,Nakabo Ayumi,Fukui Miho,Fujiwara Shohei,Sugahara Masataka,Lee-Kawabata Masaaki,Tsujino Takeshi,Koshiba Masahiro,Masuyama Tohru

Funder

Hyogo College of Medicine, 2011

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Cardiac remodeling in systemic hypertension;Kenchaiah;Med Clin North Am,2004

2. Effect of epicardial adipose tissue on diastolic functions and left atrial dimension in untreated hypertensive patients with normal systolic function;Cetin;J Cardiol,2013

3. Cardiac remodeling – concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling;Cohn;J Am Coll Cardiol,2000

4. Efficacy and safety of a 60-week treatment with candesartan in Japanese patients with mild to moderate chronic heart failure;Matsuzaki;J Cardiol,2013

5. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial;Gerdts;Hypertension,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Left atrial dysfunction and stiffness in pediatric and adult patients with Type 1 diabetes mellitus assessed with speckle tracking echocardiography;Pediatric Diabetes;2020-11-21

2. Early vs. late reverse ventricular remodeling in patients with cardiomyopathy;Journal of Cardiology;2016-07

3. Left atrial size and risk of stroke in patients in sinus rhythm;Thrombosis and Haemostasis;2016-02

4. Drugs Targeting RAAS in the Treatment of Hypertension and Other Cardiovascular Diseases;Pathophysiology and Pharmacotherapy of Cardiovascular Disease;2015